Fig. 3From: Efficacy and safety of novel oral anticoagulants in patients with atrial nonvalvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysisForest plot of the risk of major bleeding among NVAF patients with diabetes on NOACs versus warfarinBack to article page